Analyst David Risinger upgraded shares to outperform. He also raised his price target to $834 from $762.
Related Posts
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
Trump administration wants to un-fire some nuclear safety workers but can’t figure out how to reach them
The individuals, who work in an agency that overseas the nuclear stockpile, had been fired on Thursday and lost access to their government email accounts.
Foreign automaker stocks slide on Trump tariff fears
Stock prices of foreign automakers fell sharply Wednesday amid concerns the U.S. will hike tariffs on imported vehicles under President-elect Donald Trump.